Vaxcyte, Inc. (PCVX) Misses Q4 EPS by $4.13

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($5.63), $4.13 worse than the analyst estimate of ($1.50).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Alphabet added to Dow Jones Industrial Average, Verizon dropped